MedPath

Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS

Phase 3
Completed
Conditions
Pneumonia, Pneumocystis Carinii
HIV Infections
Registration Number
NCT00001013
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

To compare the safety and effectiveness of an investigational drug therapy (trimetrexate plus leucovorin calcium) with that of conventional therapy (sulfamethoxazole-trimethoprim) in the treatment of moderately severe Pneumocystis carinii pneumonia (PCP) in patients who have AIDS, are HIV positive, or are at high risk for HIV infection.

Detailed Description

New treatments are needed to reduce the mortality rate from PCP in AIDS patients and to reduce the high relapse rate found after conventional therapy. Trimetrexate (TMTX) was chosen for this trial because it was found to be much more potent than sulfamethoxazole/trimethoprim (SMX/TMP) against the PCP organism in laboratory tests. Also TMTX, in combination with leucovorin (LCV), did not cause severe toxicity in a preliminary trial. It is believed that TMTX will be more effective than SMX/TMP in treating PCP and in preventing a recurrence of PCP. Preliminary studies suggest that aerosolized pentamidine (PEN) is likely to be effective in preventing a recurrence of PCP.

Patients entered in the study are randomly assigned to TMTX / LCV or to SMX/TMP for a 21-day trial. For the first 10 days, the trial is double-blind (neither patient nor physician knows which drugs the patient is receiving), and drugs are given by intravenous infusion. TMTX is given once every 24 hours and LCV every 6 hours; SMX/TMP is given every 6 hours. Doses are determined by body size. After the first 10 days, LCV and SMX/TMP may be given orally. Doses are adjusted or treatment is changed to intravenous PEN if side effects are too severe. During the 21-day trial, zidovudine (AZT) may not be used because of possible increased bone marrow toxicity. AZT may be resumed as soon as the patient's white cell count is acceptable. Aerosolized PEN therapy is begun 7 - 10 days after completion of therapy for the acute episode. PEN is inhaled once weekly for 4 weeks, then every 2 weeks for 48 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
364
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (23)

Tulane Univ School of Medicine

๐Ÿ‡บ๐Ÿ‡ธ

New Orleans, Louisiana, United States

Charity Hosp / Tulane Univ Med School

๐Ÿ‡บ๐Ÿ‡ธ

New Orleans, Louisiana, United States

SUNY / State Univ of New York

๐Ÿ‡บ๐Ÿ‡ธ

Syracuse, New York, United States

Univ of Massachusetts Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Worcester, Massachusetts, United States

Milton S Hershey Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Hershey, Pennsylvania, United States

Univ of Rochester Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Rochester, New York, United States

Los Angeles County - USC Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Los Angeles, California, United States

Northwestern Univ Med School

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Univ Hosp of Cleveland / Case Western Reserve Univ

๐Ÿ‡บ๐Ÿ‡ธ

Cleveland, Ohio, United States

Univ of Miami School of Medicine

๐Ÿ‡บ๐Ÿ‡ธ

Miami, Florida, United States

Holmes Hosp / Univ of Cincinnati Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Cincinnati, Ohio, United States

SUNY - Stony Brook

๐Ÿ‡บ๐Ÿ‡ธ

Stony Brook, New York, United States

George Washington Univ Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Washington, District of Columbia, United States

Bronx Municipal Hosp Ctr/Jacobi Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Bronx, New York, United States

Montefiore Med Ctr / Bronx Municipal Hosp

๐Ÿ‡บ๐Ÿ‡ธ

Bronx, New York, United States

Beth Israel Med Ctr / Peter Krueger Clinic

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Mount Sinai Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Thomas Jefferson Med College

๐Ÿ‡บ๐Ÿ‡ธ

Philadelphia, Pennsylvania, United States

Julio Arroyo

๐Ÿ‡บ๐Ÿ‡ธ

West Columbia, South Carolina, United States

Louisiana State Univ Med Ctr / Tulane Med School

๐Ÿ‡บ๐Ÿ‡ธ

New Orleans, Louisiana, United States

Jack Weiler Hosp / Bronx Municipal Hosp

๐Ÿ‡บ๐Ÿ‡ธ

Bronx, New York, United States

SUNY / Erie County Med Ctr at Buffalo

๐Ÿ‡บ๐Ÿ‡ธ

Buffalo, New York, United States

City Hosp Ctr at Elmhurst / Mount Sinai Hosp

๐Ÿ‡บ๐Ÿ‡ธ

Elmhurst, New York, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath